Gene panel testing for breast cancer should not be used to confirm syndromic gene associations.

Saved in:
Bibliographic Details
Title: Gene panel testing for breast cancer should not be used to confirm syndromic gene associations.
Authors: Evans DG; 1Manchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester, M13 9WL UK.; 2Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.; 3The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX UK., Howell SJ; 3The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX UK.; 4Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK., Frayling IM; 5All-Wales Medical Genetics Service, Cardiff & Vale University Health Board, University Hospital of Wales, Cardiff, CF14 4XW UK.; 6Institute of Medical Genetics, Division of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, CF14 4XN UK., Peltonen J; 7Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku, Turku, Finland.
Source: NPJ genomic medicine [NPJ Genom Med] 2018 Nov 26; Vol. 3, pp. 32. Date of Electronic Publication: 2018 Nov 26 (Print Publication: 2018).
Publication Type: Journal Article
Journal Info: Publisher: Springer Nature in partnership with the Center of Excellence in Genomic Medicine Research at King Abdulaziz University Country of Publication: England NLM ID: 101685193 Publication Model: eCollection Cited Medium: Internet ISSN: 2056-7944 (Electronic) Linking ISSN: 20567944 NLM ISO Abbreviation: NPJ Genom Med Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2056-7944
DOI:10.1038/s41525-018-0071-6